Hi all,
In terms of protection from people using cheap generic forms of Zilosul, I'm looking into how protected we are.
Do we have an exclusive rights of distribution of Zilosul and Rhinosul? I can't find if that has been completed.
Does anyone know if bene pharmachem manufacture a generic version that maybe used via some other means. I know this is the greatest risk with repurposed drugs.
I also recollect that the human version is not the same as the animal equivalent. So I assume Zilosul is unique for this us or is this not correct?
I'll keep reading but if anyone can enlighten me to these questions please do!
Could PAR be the next CSL?, page-51
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |